Literature DB >> 29294338

Innervation Changes Induced by Inflammation in the Murine Vagina.

Harman Sharma1, Esther Ji1, Pauline Yap1, Pat Vilimas1, Melinda Kyloh2, Nicholas J Spencer2, Rainer V Haberberger1, Christine M Barry3.   

Abstract

Vulvodynia is a prevalent chronic pain disorder associated with high medical costs and often ineffective treatments. The major pathological feature is proliferation of vaginal nerve fibers. This study aimed to develop a highly reproducible animal model to study neuroproliferation in the vagina and aid the identification of appropriately targeted treatments for conditions such as vulvodynia. Mild chronic inflammation was induced using microinjection of complete Freund's adjuvant in the distal vagina of C57Bl/6 mice. Control mice received saline. Inflammation and innervation density were assessed at 7 and 28 days after a single administration or 14 days following repeated administration of complete Freund's adjuvant or saline. Histochemistry and blinded-analysis of images were used to assess vaginal morphology (H & E) and abundance of macrophages (CD68-labeling), mast cells (toluidine blue staining, mast cell tryptase-immunoreactivity), blood vessels (αSMA-immunoreactivity) and nerve fibers immunoreactive for the pan-neuronal marker PGP9.5. Subpopulations of nerve fibers were identified using immunoreactivity for calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY). Single administration of complete Freund's adjuvant resulted in vaginal swelling, macrophage infiltration, vascular proliferation and increased abundance of nerve fibers immunoreactive for CGRP, SP, VIP and/or PGP9.5 but not NPY, evident at seven days. Inflammation further increased following repeated administration of complete Freund's adjuvant but nerve fiber proliferation did not. Nerve fiber proliferation continued to be evident at 28 days. The inter-individual differences within each treatment group were small, indicating that this model may be useful to study mechanisms underlying vaginal nerve fiber proliferation associated with inflammation.
Copyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CGRP; VIP; innervation; substance P; vaginal inflammation; vulvodynia

Mesh:

Substances:

Year:  2017        PMID: 29294338     DOI: 10.1016/j.neuroscience.2017.12.026

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

Review 1.  High-Intensity Laser Therapy (HILT) as an Emerging Treatment for Vulvodynia and Chronic Musculoskeletal Pain Disorders: A Systematic Review of Treatment Efficacy.

Authors:  Małgorzata Starzec-Proserpio; Marcela Grigol Bardin; Julie Fradette; Le Mai Tu; Yves Bérubè-Lauzière; Josianne Paré; Marie-Soleil Carroll; Mélanie Morin
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

Review 2.  Vulvodynia.

Authors:  Sophie Bergeron; Barbara D Reed; Ursula Wesselmann; Nina Bohm-Starke
Journal:  Nat Rev Dis Primers       Date:  2020-04-30       Impact factor: 52.329

3.  New models to study vulvodynia: Hyperinnervation and nociceptor sensitization in the female genital tract.

Authors:  Christine M Barry; Kalyani K Huilgol; Rainer V Haberberger
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

4.  Emerging Evidence of Macrophage Contribution to Hyperinnervation and Nociceptor Sensitization in Vulvodynia.

Authors:  Christine Mary Barry; Dusan Matusica; Rainer Viktor Haberberger
Journal:  Front Mol Neurosci       Date:  2019-08-06       Impact factor: 5.639

5.  Clodronate Treatment Prevents Vaginal Hypersensitivity in a Mouse Model of Vestibulodynia.

Authors:  Joel Castro; Andrea M Harrington; Fariba Chegini; Dusan Matusica; Nick J Spencer; Stuart M Brierley; Rainer V Haberberger; Christine M Barry
Journal:  Front Cell Infect Microbiol       Date:  2022-01-18       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.